226 related articles for article (PubMed ID: 21993679)
1. Treatment advances have not improved the early death rate in acute promyelocytic leukemia.
McClellan JS; Kohrt HE; Coutre S; Gotlib JR; Majeti R; Alizadeh AA; Medeiros BC
Haematologica; 2012 Jan; 97(1):133-6. PubMed ID: 21993679
[TBL] [Abstract][Full Text] [Related]
2. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
3. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.
Park JH; Qiao B; Panageas KS; Schymura MJ; Jurcic JG; Rosenblat TL; Altman JK; Douer D; Rowe JM; Tallman MS
Blood; 2011 Aug; 118(5):1248-54. PubMed ID: 21653939
[TBL] [Abstract][Full Text] [Related]
4. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
5. Early death in acute promyelocytic leukemia: Evidence from a rural cancer center.
Golamari KR; Mikkilineni A; Chappidi S
Indian J Cancer; 2020; 57(4):451-456. PubMed ID: 33078753
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H; Kurokawa M
Ann Hematol; 2021 Oct; 100(10):2613-2619. PubMed ID: 34308494
[TBL] [Abstract][Full Text] [Related]
8. Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Lengfelder E; Hanfstein B; Haferlach C; Braess J; Krug U; Spiekermann K; Haferlach T; Kreuzer KA; Serve H; Horst HA; Schnittger S; Aul C; Schultheis B; Erben P; Schneider S; Müller-Tidow C; Wörmann B; Berdel WE; Sauerland C; Heinecke A; Hehlmann R; Hofmann WK; Hiddemann W; Büchner T;
Ann Hematol; 2013 Jan; 92(1):41-52. PubMed ID: 23090499
[TBL] [Abstract][Full Text] [Related]
9. Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.
Abrahão R; Ribeiro RC; Medeiros BC; Keogh RH; Keegan TH
Cancer; 2015 Nov; 121(22):3990-7. PubMed ID: 26264598
[TBL] [Abstract][Full Text] [Related]
10. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
[TBL] [Abstract][Full Text] [Related]
11. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
[TBL] [Abstract][Full Text] [Related]
12. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
[TBL] [Abstract][Full Text] [Related]
13. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992.
Tezcan H; Barnett MJ; Bredeson CN; Reece DE; Shepherd JD; Dalal BI; Horsman DE; Klingemann HG; Nantel SH; Spinelli JJ
Leuk Lymphoma; 1995 Feb; 16(5-6):439-44. PubMed ID: 7787754
[TBL] [Abstract][Full Text] [Related]
15. Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.
Sobas M; Czyż A; Montesinos P; Armatys A; Helbig G; Hołowiecka A; Pluta A; Zarzycka E; Piątkowska-Jakubas B; Majcherek M; Lewandowski K; Gołos A; Paluszewska M; Podhorecka M; Oleksiuk J; Skręt A; Hawrylecka D; Guzicka-Kazimierczak RE; Wątek M; Gromek T; Charliński G; Grosicki S; Holojda J; Miśkiewicz W; Martinez-Cuadrón D; Sanz MA; Wróbel T; Wierzbowska A; Giebel S
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):105-113. PubMed ID: 31874794
[TBL] [Abstract][Full Text] [Related]
16. Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.
Norsworthy KJ; Avagyan A; Bird ST; Li Y; Akhtar S; Liao J; Wernecke M; Deisseroth AB; Chuk M; MaCurdy TE; Swain R; Kelman JA; Farrell AT; de Claro RA; Pazdur R; Blumenthal G; Graham DJ
Leukemia; 2020 Nov; 34(11):3082-3084. PubMed ID: 32518418
[No Abstract] [Full Text] [Related]
17. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
[TBL] [Abstract][Full Text] [Related]
18. Addressing the room for improvement in management of acute promyelocytic leukemia.
Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
20. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
